Health

Results: 217-228 of 5630

PR Newswire associated0

STEERLife Redefines Potent Drug Development with Clean, Green, Continuous Processing

Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec

Guelph General Hospital adds digital pathology to cloud service from Sectra--enables integrated diagnostics for improved patient care

AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London

Tsingke Showcases at AACR 2025 -- Advancing Global Cancer Research with Integrated Synthesis Solutions

Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

71.4% of MetaXplore™ reports from 4,616 patients identified actionable results

Microba Announces Landmark GI Study Results From Over 4,600 Patients

Image created by Clara Leibenguth for Stanford University; featured on cover of May 2025 issue of Nature Neuroscience.

Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience

The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 1

BeiGene Showcases Strength of Hematology Portfolio at EHA 2025 with New Data Highlighting BRUKINSA’s Leadership and Next-Generation Innovation

PR Newswire associated0

Piramal Pharma Limited Announces Results for Q4 and FY2025

Increased fatigue may signal hidden nutrient deficiencies, say Nature's Best experts